Colin Goddard, Chief Executive Officer at OSI PHARMACEUTICALS INC (OSIP), sold 24,000 shares at $30.05 ($723K) on 2006-06-02, disclosed to the SEC on 2006-06-06.
Scheduled sale ($723k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 9,468 | $284K | 39.3% |
| 2 | $30.02 | 400 | $12K | 1.7% |
| 3 | $30.03 | 502 | $15K | 2.1% |
| 4 | $30.05 | 400 | $12K | 1.7% |
| 5 | $30.08 | 30 | $902 | 0.1% |
| 6 | $30.09 | 2,200 |
| $66K |
| 9.2% |
| 7 | $30.25 | 10,303 | $312K | 43.1% |
| 8 | $30.28 | 697 | $21K | 2.9% |
| Total | $30.13 avg | 24,000 | $723K | 100% |
| Filing → |
| OSIP | SELL | 2010-03-03 | $3.6M | — | Filing → |
| OSIP | SELL | 2007-06-06 | $1.5M | — | Filing → |
| OSIP | SELL | 2006-08-29 | $982K | — | Filing → |